This study tested in vitro activity of the essential oil from flowers of Calendula officinalis using diskdiffusion techniques. The antifungal assay results showed for the first time that the essential oil has good potential antifungal activity: it was effective against all 23 clinical fungi strains tested.
Calendula officinalis L. (Asteraceae) is an annual herb with yellow to orange flowers, native to the Mediterranean region. It is also known as pot marigold, a name historically associated with its use in soups and stews to combat illnesses (1) and has a long history of safe use as a medicine in the treatment of inflammation and skin wounds (2) . The plant contains esquiterpenes glycosides, saponins, xanthophylls, triol triterpenes, flavonoids and volatiles. Chalchat and Cols (3) studied the essential oil of C. officinalis flowers cultivated in the Massif Central, France, and obtained sesquiterpene alcohol and mainly α-cadinol by using steam distillation. Radulescu and Cols (4) studied flowers from Romania by headspace and steam distillation, and found δ-cadinene plus 1,3,5-cadinatriene and α-muurolol as the major compounds, respectively. Because of the economic value of C. officinalis as an herbal medicine and its wide use in cosmetics, perfumes, pharmaceutical preparations and food, we decided to study the acclimatization of C. officinalis in southeast Brazil. The aim of the present work was to study in vitro antifungal activity of the essential oil from C. officinalis flowers, as determined by agar disk diffusion, on 23 clinical fungal strains.
Plant material
The 
Steam distillation
The essential oil was obtained in a Clevenger apparatus by steam distillation. After 3 hours of steam distillation, l50 g of dried sample was extracted with 500 ml of water. The water collected was re-extracted with 3 x 50 ml hexane. After drying in anhydrous Na 2 SO 4 , hexane was concentrated in a vacuum rotator evaporator apparatus to 47 mg to yield 0.1% w/w by weight of dry material (5).
Microorganisms used and growth conditions
The antimicrobial activity of the essential oil from Calendula officinalis flowers was evaluated using a panel which included 
Disc diffusion method
In vitro antifungal activity of the C. officinalis essential oil was determined by the agar disk diffusion method according to Rubio et al. 2003 (6) . Briefly, a suspension of each tested microorganism (2.0 ml of 10 5 cells per ml) was carefully mixed in a tube with 18 ml of Mueller Hinton Agar (MHA), and then poured on Petri plates. Sterile filter-paper discs (Whatman No. 1, 6.0 mm in diameter) were impregnated with 15 µl of the oil and placed on the inoculated plates. Control disks containing 15 µl of the physiological saline and Nystatin (100 U.I. or 20 µg/disc, Cecon, São Paulo, Brazil) were used. These plates were allowed to dry at room temperature for 2 h, and were incubated at 25ºC for 48 h. The diameters of the inhibition zones were measured in millimeters and their means were calculated. All the tests were performed in duplicate (7). Twenty-three yeast strains were tested, as listed in Table 1 .
The main constituents of the essential oil were the following: sesquiterpene hydrocarbons (68.0%) and sesquiterpenols (27.0%). δ-cadinene (22.53%), α-cadinol (20.40%) and epi-α-muurolol (12.87%). The analyses were performed by GC and GC-MS as described by Gazim et al. (8) .
Many antifungal agents are available for the treatment of candidal infections, and these are available in several pharmaceutical forms for either topical or systemic use. The major agents belong either to the polyenes, such as amphotericin B and nystatin; or to the azoles, such as itraconazole and fluconazole. However, because of the need for extended treatment, the high cost, toxicity and limited action of the classic drugs, new and effective products are desirable to treat these fungal infections. The antifungal effect of essential oils (EO) of many aromatic plants has been described in several studies (9) . The essential oils rich in cadinene isomers are widely reported to possess high levels of anticandidal activity (10) . Our data indicate that the oil of C. officinalis flowers exhibited antifungal activity against all investigated yeasts, including the clinical pathogens obtained from reference stocks as well as those recently isolated. This oil provided more interesting results than Nystatin, a fungicide used for topical treatment of mucocutaneous candidiasis.
As seen in Table 1 , discs impregnated with 15 µg of C. officinalis flower oil produced inhibition zones ranging from 11 to 30 mm of the diameter. The widest (28-30 mm) were obtained against Candida parapsilosis (isolates 11 and 12), Candida glabrata (isolate 15) and Rhodotorulla sp. (isolate 23). The oil also showed high activity, with inhibition zones of 20-27 mm, against Candida albicans (Isolates 3 and 7) , Candida We note that according to the manufacturer of the Nystatin disks, all 23 samples of yeasts tested were sensitive to Nystatin (inhibition diameter above 10 mm). However, the oil of C. officinalis flowers showed greater variability among the different isolates than did Nystatin, which ranged between 11 and 13 mm. It is possible that the wider range in the sensitivity profile shown by the oil of C. officinalis flowers may be advantageous, because these are widely available and demonstrate a wide action spectrum against pathogenic fungi. Moreover, the human therapeutic response to medicine is not uniform, as suggested by the in vitro assays with Nystatin.
